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Abstract
Background: The most popular methods for significance analysis on microarray data are well
suited to find genes differentially expressed across predefined categories. However, identification
of features that correlate with continuous dependent variables is more difficult using these
methods, and long lists of significant genes returned are not easily probed for co-regulations and
dependencies. Dimension reduction methods are much used in the microarray literature for
classification or for obtaining low-dimensional representations of data sets. These methods have an
additional interpretation strength that is often not fully exploited when expression data are
analysed. In addition, significance analysis may be performed directly on the model parameters to
find genes that are important for any number of categorical or continuous responses. We
introduce a general scheme for analysis of expression data that combines significance testing with
the interpretative advantages of the dimension reduction methods. This approach is applicable both
for explorative analysis and for classification and regression problems.
Results: Three public data sets are analysed. One is used for classification, one contains spiked-in
transcripts of known concentrations, and one represents a regression problem with several
measured responses. Model-based significance analysis is performed using a modified version of
Hotelling's T2-test, and a false discovery rate significance level is estimated by resampling. Our
results show that underlying biological phenomena and unknown relationships in the data can be
detected by a simple visual interpretation of the model parameters. It is also found that measured
phenotypic responses may model the expression data more accurately than if the design-
parameters are used as input. For the classification data, our method finds much the same genes as
the standard methods, in addition to some extra which are shown to be biologically relevant. The
list of spiked-in genes is also reproduced with high accuracy.
Conclusion: The dimension reduction methods are versatile tools that may also be used for
significance testing. Visual inspection of model components is useful for interpretation, and the
methodology is the same whether the goal is classification, prediction of responses, feature
selection or exploration of a data set. The presented framework is conceptually and algorithmically
simple, and a Matlab toolbox (Mathworks Inc, USA) is supplemented.
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Background
An important part of expression data analysis is the signif-
icance analysis of genes, in which relevant features are
found among thousands of irrelevant ones. Two widely
used algorithms for significance analysis are SAM [1] and
Limma [2]. These methods are well suited for assessing
differences of expression across classes or levels in an
experimental design. Dimension reduction methods such
as principal component analysis (PCA) and partial least
squares regression (PLSR) [3-5] is another group of popu-
lar tools for expression data analysis. These methods
attempt to describe the underlying variation of the data in
a low-dimensional space, enabling the use of statistical
methods that cannot deal with the high number of corre-
lated gene-expressions in the original data. The real signal
is separated from random noise, and the components of
the dimension reduction can often be interpreted biolog-
ically.
A much used dimension reduction method is PCA [3,4].
This is an unsupervised method that describes the main
features of a data set using a small number of orthogonal
components. The computational method of singular
value decomposition (SVD) is in many aspects the same
as PCA, and often it constitutes the main part of the PCA
algorithm. When background knowledge is available
about the objects, supervised methods may be used to
identify genes that associate with this information. For
instance, t-tests may be used to discriminate between
classes in an experimental design. Also, correlation tests
such as Spearman's correlation may be used to probe
expression profiles for similarity with continuous
responses. PLSR [3,5] is a very powerful dimension reduc-
tion method which can utilise any sort of background
information directly in the decomposition. PLSR compo-
nents are designed to optimally describe the dependent
variables in terms of the expression data. The main focus
of PLSR in the microarray literature has been on classifica-
tion, where a regression model is trained to fit a binary
array representing class labels. Many methods are availa-
ble to convert the prediction model to a classification rule,
for instance by discriminant analysis of the PLSR compo-
nents [6,7]. We use the intuitively pleasing property that
the predicted, validated responses may be discretised
directly in order to predict class-assignments. When PLSR
is used for classification it is referred to as discriminant
PLSR (DPLSR) or PLS discriminant analysis (PLS-DA).
Nguyen and Rocke were the first to demonstrate how
DPLSR may be applied to classify cancers based on expres-
sion data [6,7]. In that work, they used an additional dis-
criminant analysis for the final classification. PLSR has
also successfully been used to model patient survival
times [8] or cell cycle data [9], which are applications
where a continuous response is used directly as input.
Overviews of dimension reduction methods for analysis
of microarray data are given in [10,11].
The dimension reduction methods offer a new way of
doing significance analysis on expression data. The under-
lying variation of interest is described by a limited number
of components, also known as latent variables (LVs). The
LVs are axes in a coordinate system that span, depending
on the dimension reduction method used, the most rele-
vant structures in the data set. Each object (array) is asso-
ciated with a limited number of scores, which represent
the projection of the measurements onto the latent axes.
There is also a loading vector for each component, provid-
ing a mapping between the latent and the original varia-
bles (features). The score vectors thus span interesting
directions in the original feature space, and the accompa-
nying loading vectors hold the contribution of the fea-
tures in those directions. Jack-knife is a method which can
be used to assess the significance of variables from the sta-
bility of cross-validated model parameters [3,12]. Genes
important for class separation may be found by jack-knife
of the components that best span the different classes. We
use a modified version of Hotelling's T2 test statistic [13]
that is specially tailored for cross-validated data. The
framework presented is a very general tool for significance
testing, and it is applicable in principle to any dimension
reduction method from which cross-validated loadings
can be obtained. Once a dimension reduction method is
chosen based on the data available or the experimental
setup, the same methodology for significance analysis
may be used whether one, several or no responses are
included in the modelling. The dependent variables may
describe continuous phenotypic information, categorical
information or a combination of both.
We apply our framework for significance analysis on three
publicly available expression data sets, including one with
known spiked-in transcripts. Differences between PCA
and PLSR-methods will be explored, and the results will
be compared to SAM and Limma where possible. For ordi-
nary PLSR or DPLSR, some of the weaker correlation pat-
terns between the expression data and the responses may
be overlooked in the modelling. We have therefore cho-
sen to use a variant of PLSR called Bridge-PLSR [14]. This
method is able to extract all information relevant to the
responses in the first components, and is therefore better
suited for this kind of significance analysis. The false dis-
covery rate (FDR) is estimated by resampling to provide a
threshold for significance [9,15]. The set of parameters
obtained from either of the dimension reduction methods
in this work is referred to as a bilinear model. This reflects
that the components representing the data are linear in
both the rows and the columns. The same term is used
also about the mathematical formulation of how the data
are represented by scores and loadings, but the exactBMC Bioinformatics 2007, 8:346 http://www.biomedcentral.com/1471-2105/8/346
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meaning in each case should be clear from the context.
Bold uppercase letters denote matrices, and bold lower-
case letters describe column-vectors. An expression data
set is arranged in an array X with experiments along the
rows and with a column for each feature.
A toolbox written in Matlab (Mathworks Inc. USA) with
the code used in this work is provided under the GNU
general public license (see additional file 1).
Results
Smoker transcriptome
We first look at a data set that investigates the effects of
smoking on human airway transcripts [15]. Data are avail-
able from three groups of subjects according to their
smoking history. The original article reports significant
differences both between a group of smokers compared to
subjects that have never been smoking, and between
former smokers and the group of never smokers. A PCA of
the expression data X reveals that there is a large source of
variation in the data that does not correspond to the avail-
able group information. In figure 1, a PCA score plot of
the two first components is given, where the objects are
coloured according to the classes "Never", "Former", and
"Current". Unreported experimental factors, for instance a
change in laboratory procedures, may be responsible for
the separation of objects into two clusters along the first
component. In the corresponding loading plot in figure 2,
the 725 most significant genes from the PCA analysis are
given in green. These genes span mainly the unreported X-
variation and are not important for the smoking-induced
differences of expression. The Venn diagram in figure 3
confirms that the genes detected by PCA are to a large
degree irrelevant for classification of these data.
The PCA-analysis indicates that the group information
should be allowed to guide the decomposition if any
genes related to smoking are to be found. We know that a
minimum of K - 1 independent variables are needed for a
linear separation of K classes. For instance, one gene
measured for several subjects may in theory be used to dif-
ferentiate between two classes, while a minimum of two
genes are needed for assignments into three classes. Due
to co-regulation and inter-dependencies between genes,
such single, descriptive features are usually both unin-
formative and hard to find. However, dimension reduc-
tion offers independent linear combinations of genes that
may be used instead. If Y is a binary matrix holding the
class information for each object, a good linear separation
based on the expression data may be obtained with com-
ponents that span all the Y-related variance in X. In
Bridge-PLSR, this variance may be completely described in
a minimum number of components. The score plot from
a two-component Bridge-PLSR model is given in figure 4.
PCA loadings Figure 2
PCA loadings. The loadings from the PCA with the 725 most 
significant genes given in green. The actual number of signifi-
cant genes is arbitrary, and corresponds to the number esti-
mated from resampling of a Bridge-PLSR model. It is seen 
that the significant genes are scattered outside an elliptic 
shape centred at the origin. Genes with loadings of a large 
magnitude that vary little in the cross-validation are called 
significant. As neither of the components span the smoking 
history of the subjects, these features are irrelevant for clas-
sification.
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PCA scores Figure 1
PCA scores. The scores from the PCA of the smoker-data 
plotted for the two first components. There is a major 
source of variation along the first component that does not 
correspond to the smoking history of the test subjects. 
These components are only able to explain 1% of the vari-
ance in Y.
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Here, three groups corresponding to the predefined
classes are revealed. This model explains 54% of Y,
whereas an ordinary PLSR for comparison explains 45%
in two components. Jack-knife is performed based on a
full leave-one-out cross-validation, and the significant fea-
tures are given in the loading plot in figure 5. The green
spots correspond to features called significant by both
SAM and Bridge-PLSR, whereas the red spots indicate sig-
nificant genes not found by SAM. Neighbouring genes in
the loading plot have similar profiles, whereas genes in
opposite quadrants are negatively correlated. Also, the
arrays in a specific area of the score plot have a high
expression value for the genes in the corresponding area
of the loading plot. As the significant genes span mainly
the first component, they discriminate well between
smokers and never-smokers, according to the score plot.
Along the second component, which separates former
smokers from the rest, fewer significant genes are found.
This indicates that this correlation is weaker and more sus-
ceptible to random variations in the data. It is seen, how-
ever, that Bridge-PLSR finds more genes than SAM along
this direction. Any significant genes along the second
component describes smoking-induced transcriptomic
changes among the former smokers.
A Venn diagram which compares the significant genes
found with Bridge-PLSR, SAM and Limma is given in fig-
ure 6. All methods agree on the significance calls for the
majority of the genes, however, Bridge-PLSR finds an
additional 185 genes which are undetected by the other
methods. To verify that these genes are not primarily false
positives, the genes are annotated and their biological sig-
nificance with regard to smoking is evaluated. A compre-
hensive list of our findings is given as supplementary
information (see additional file 2). Of the genes identified
as differentially expressed by Bridge-PLSR, only 66 have
unknown or poorly known biological function. An addi-
tional 14 have well understood biological function often
related to the natural system, but with no readily apparent
link to smoking or lung damage. Of the remaining genes,
49 are known to be involved in regulation of cell growth,
cell cycle, or apoptosis, processes known to be affected by
smoking [16,17]. Seven of these genes as well as another
14 genes on the list not related to cell growth, have been
shown to be involved in various forms of lung cancer. As
the majority of lung cancer sufferers are smokers or previ-
ous smokers, these genes can be linked to smoking
directly. Another interpretation is that these genes change
early in the cancer development process. Seven genes are
identified that have been reported to take part in lung
Bridge-PLSR scores Figure 4
Bridge-PLSR scores. The two first Bridge-PLSR score-vectors 
describing the smoker-data are plotted. These components 
account for 54% of the (calibrated) variance of Y, but only 
11% of the X-variance is explained by the model. The first 
component distinguishes well between current and never 
smokers, while the second component spans the minute var-
iation that separates former smokers from the rest.
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Significant outcomes from PCA Figure 3
Significant outcomes from PCA. Venn diagram comparing the 
significant genes from PCA with SAM and Limma. The over-
lap between the supervised methods and the unsupervised 
PCA is very small for this data set. This is expected as the 
principal components do not span the groups of different 
smoking history.BMC Bioinformatics 2007, 8:346 http://www.biomedcentral.com/1471-2105/8/346
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development, this is not surprising as smoking can cause
dramatic changes in the airways. In addition to cancer, we
identify 17 genes that are related to other diseases in the
lungs and bronchia, such as asthma, inflammation, fibro-
sis, or response to metallic toxins. Another large group of
genes belongs to the protein life cycle, particularly the
ribosome, or the ubiquitin cycle. This could point to an
overall change in the rate of protein turnover caused by
smoking. This is consistent with the results of Tomfohr et
al. [18], who analysed the same data set with gene set
enrichment analysis. Five genes are also found that are
known to be expressed in lungs, but for which we find no
link to cancer development or lung damage in the litera-
ture. Overall it seems that of the genes for which biologi-
cal background information is available, the majority
relate to biological processes that are influenced by smok-
ing. The additional genes found by Bridge-PLSR are there-
fore unlikely to be false discoveries.
For prediction purposes, ordinary PLSR seems to be supe-
rior to Bridge-PLSR. The best predictive PLSR model is
obtained for two components, with an explained Y-vari-
ance of 32%. The best predictive Bridge-PLSR model is a
one-component solution with a cross-validated explained
variance in Y of 20%. The residual mean squared error of
prediction even increases slightly when two components
are used. Caution must therefore be used when interpret-
ing the second component. They are both included here
because the main goal of the analysis is significance test-
ing. Hotelling's T2-test using only one component corre-
sponds to an ordinary one-sample t-test, and is, in this
case, only able to separate between the groups "Never"
and "Current". In order to find genes that might be rele-
vant for former smokers, the second component must be
investigated. The jack-knife is believed to reject most of
the genes that cause the residual error to increase, as those
genes have a high variance across cross-validation seg-
ments. For prediction purposes, the model with the low-
est residual error might be used instead. It should be
noted, however, that even if the Bridge-PLSR or PLSR-
model with one or two components, respectively, is opti-
mal for prediction, neither will be able to predict former
smokers.
A ridge parameter γ  controls the influence of Y  in the
decomposition. A small value of this parameter ensures
that the first Bridge-PLSR components span the directions
of maximum covariance between X and Y. This is ideal
Significant outcomes from Bridge-PLSR Figure 6
Significant outcomes from Bridge-PLSR. A venn diagram 
comparing the significant genes from Bridge-PLSR with SAM 
and Limma. At a significance level of 5%, the T2-test finds 725 
significant genes, while SAM and Limma find a total of 668 
and 471 features, respectively. The majority of the genes are 
found by all three methods.
Bridge-PLSR loadings Figure 5
Bridge-PLSR loadings. Loadings from the Bridge-PLSR of the 
smoker-data are plotted for the two first components. The 
blue spots represent features that are not found significant by 
the jack-knife procedure. The green spots are genes that are 
found significant by both SAM and Bridge-PLSR, while the red 
spots are called significant by the T2-test but not by SAM. The 
significant features span mainly the direction of smokers vs. 
never smokers, but Bridge-PLSR detects some genes relevant 
for former smokers as well.
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from the point of view of significance analysis, as the
major components will span all the Y-relevant variance.
However, if γ = 0, the maximum number of components
is limited by the rank of Y, which for these particular data
is two. For explorative reasons, γ is set to a default value of
0.01 throughout this work in order to enable interpreta-
tion also of later components. For the first two compo-
nents, this has no visible effect compared to a γ-value of
zero. Components three and four, however, are almost
identical to the first two PCA components in figure 1 (not
shown). This is a further verification that the Bridge-PLSR
is able to separate the Y-relevant structures in X from tech-
nical and other irrelevant variation. It is possible to opti-
mise both the ridge parameter and the number of
components to minimise the residual error of the bilinear
model. This would require an extra layer of validation, for
instance by cross model validation [19], to obtain unbi-
ased error estimates. As the primary goal in this work is
significance analysis, such an optimisation is out of scope.
However, a supplementary response surface is provided
for reference, along with the ordinary PLSR results (see
additional file 3). It can be seen that the cross-validated
error variance is robust with regard to γ for small values of
the parameter.
Analysis by ordinary PLSR is performed for the sake of
comparison. This model uses two components to separate
never and current smokers, and additional two or three
components are needed to describe the former smokers.
The optimal number of components according to the
cross-validation is two, but the majority of the significant
genes found by this model span only the irrelevant X-
information (not shown). Because of the irrelevant, dom-
inating structure in X, Bridge-PLSR is a much better choice
for significance analysis in this case.
Spiked-in data
A further analysis is performed with Affymetrix spike-in
data in a constant human background [20]. The spiked-in
transcripts hybridise to 42 known probe sets, however,
several authors report that also other probe sets show dif-
ferential expression due to sequence or function similar-
ity. Sheffler et al. [21] remove 56 such genes as outliers
prior to analysis. Two independent groups [22,23] suggest
that additional 22 or 23 probe sets, respectively, should be
added to the original list of known spike-ins. These lists
differ in a single probe set, which is known to have iden-
tical sequence to one of the spiked-in genes for 5 of 11
probe pairs. We include the 22 extra genes which are sug-
gested by both groups in our analysis, yielding a total of
64 spike-in probe sets. Bridge-PLSR with jack-knife finds
all these genes among the 66 most significant ones. An
estimated FDR of 0.01 results in 69 significant genes, cor-
responding to a true FDR of 7%. The five false positives are
the probe sets "203173_s_at", "204890_s_at",
"204891_s_at", "217019_at", and "200822_x_at". The
maximum squared correlation coefficients between the
expression values of these probe sets and the concentra-
tion profiles are, respectively, r2 ∈ {0.92, 0.88, 0.86, 0.33,
0.29}. For comparison, r2 for the list of true positives
range from 0.39 to 0.74. In passing, it is noted that the
three false positives with high correlation are included
also in the outlier-list of Sheffer et al. [21].
Rat liver study
A data set investigating liver damage in rats after exposure
to toxic doses of paracetamol is also analysed [24]. In
addition to design information of dose and time of expo-
sure, several pathological variables based on blood and
tissue chemistry are available for the rats examined. There
is an abundance of possible comparisons in these data,
and analysis by Limma or SAM is therefore difficult. We
perform an analysis by SAM in which two groups of
"high" and "low" dosage are defined for each of the four
time-points of the design. The drastic treatment some of
these rats receive induces profound genetic responses,
leading to a long list of differentially expressed features.
Testing for all 28 contrasts defined by the 8 groups, SAM
assigns significance to 50% of the genes at a significance
level of 0.001. This result verifies something that might be
expected – that poisoning of an organism can affect sev-
eral biological processes that in turn involve many genes.
Investigation of more complex relationships based on
these methods is not straightforward.
PLSR is well suited for handling both multiple compari-
sons and continuous responses. The score plot from a
Bridge-PLSR model with all available response informa-
tion in Y  is given in figure 7. The spots are coloured
according to the administered drug-doses. The low doses
are clearly separated from the toxic doses along the first
component, but the classes within those two groups are
mixed together. The dashed lines envelope three groups
that are related to the time from drug exposure to
necropsy. The lower group consists of the 6-hour design
points, the upper group corresponds to the 48-hour
points, while in the middle group the 18- and 24-hour
points are mingled together. The second component is
thus related to time since exposure. A leave-one-out cross-
validation is performed also for these data. The optimal
model for prediction is obtained after four components,
with a residual variance of 47%. However, we are inter-
ested mainly in the genes which are differentially
expressed across dose and time. We therefore use a two-
component model in the significance analysis, with a pre-
diction error of 58%. For these data with much structure
in Y, the differences between the results from Bridge-PLSR
and ordinary PLSR are small. All predictive components
describe the same phenomena, and the residual errors are
similar, both in a calibrated and validated sense. For refer-BMC Bioinformatics 2007, 8:346 http://www.biomedcentral.com/1471-2105/8/346
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ence, the full response surface including several values γ of
is given as supplementary information (see additional file
3).
A helpful plot is the Y-loading plot in figure 8. Here, each
spot corresponds to a response-variable, and the predicta-
bilities are given by the associated colour-bar. The colour
of a spot reflects the cross-validated, explained variance
for that variable, given in percent of the true response's
variation. The variables with red spots are very well pre-
dicted while the blue spots represent variables that cannot
reliably be modelled based on the expression data. Two
variables which have high predictive abilities and are cor-
related with the dose are ALT (alanine aminotransferase)
and AST (aspartate aminotransferase). Increased levels of
these enzymes in the blood stream are diagnostic markers
for liver damage. The large degree of explained variance
for these variables indicates that the first component actu-
ally describes liver injury directly, rather than just the con-
centration of paracetamol in the rats. Because the
individual responses to the drug vary, these markers are
better suited to model the genetic response to overdose
than the design is. This information should be included
also in the interpretation of the scores in figure 7. It is seen
that the response to overdose peaks between 18 and 24
hours after exposure, as these groups span the first compo-
nent better than the 6- and 48-hour groups. After 48
hours, metabolism may have disposed of some of the
paracetamol, the liver-cells may have started to repair, and
the levels of ALT and AST in the blood have started to
decrease. Other correlations seen in figure 8 may also be
of interest. Liver damage seems to be associated with
increased concentrations of total bile acids and blood
urea nitrogen, and there is also an indication that the level
of cholesterol decreases. The reduced glutathione level in
the liver tissue increases with time after poisoning, and
the level of blood albumin seems to decrease accordingly.
An estimated FDR significance cutoff of 0.1% yields 25%
significant features for the Bridge-PLSR model. The X-
loading plot is given in figure 9, with the significant genes
marked by green spots. The majority of these features span
the component describing liver injury, but some are also
found that vary with time. The significant genes found by
SAM are scattered more uniformly over the same loadings,
making any systematic trends hard to detect (not shown).
Bridge-PLSR Y-loadings Figure 8
Bridge-PLSR Y-loadings. Bridge-PLSR Y-loadings for a two-
component model of the rat-liver data. Each point represents 
an Y-variable, and the percent explained, validated variance 
for each response is indicated by the colour-bar on the right. 
The variables are the design parameters Dose and Time, the 
concentrations of reduced (RedG) and oxidised (OxG) glu-
tathione levels in the liver, and the concentrations in the 
blood of sorbitol dehydrogenase (SDH), total bile acids 
(BILE), alkaline phosphatase (ALP), aspartate aminotrans-
ferase serum (AST), alanine aminotransferase (ALT), total 
protein (TP), albumin (ALB), blood urea nitrogen (BUN), 
creatinine (CREA) and cholesterol (CHOL). The diagnostic 
markers for liver injury ALT and AST is highly predictive for 
the first component, while the second component is related 
to time since exposure.
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Bridge-PLSR scores Figure 7
Bridge-PLSR scores. The score plot for a two-component 
Bridge-PLSR model of the rat-liver data. Each array is repre-
sented by a spot coloured according to the administered 
drug-dose. The dashed lines indicate the location of design-
points corresponding to different times of exposure. Two 
groups of high and low dosage can be seen along the first 
component, and the second component seems to model a 
time-effect. The two-component model accounts for 47% of 
the total variance in Y.BMC Bioinformatics 2007, 8:346 http://www.biomedcentral.com/1471-2105/8/346
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Discussion
Dimension reduction methods are explorative in nature,
and the decomposition attempts to find components that
describe as much structure as possible using a small
number of components. This is a very effective way to
detect the sources of variation in large data tables, and vis-
ual inspection of score and loading plots enables discov-
ery of unknown phenomena. The information carried by
the components often corresponds to underlying biologi-
cal processes, greatly simplifying interpretation of the
results. Comparison of score and loading plots forms a
central interpretative tool for mapping measured genetic
responses to different subjects or levels of an experimental
design. The dimension reduction methods may be vulner-
able to outliers and systematic noise, and it is important
that the results are properly validated and understood.
The inspection of scores and loadings can be used as an
aid in the discovery of bad arrays or bad spots, respec-
tively.
Most genes are known to interact with other genes in
potentially complex cellular networks. Investigation of
one gene at a time is therefore not optimal for a good
understanding of a biological system. The dimension
reduction methods attempt to find linear combinations of
genes that describe the data well, and are therefore better
equipped to model co-regulated genes. The representation
of expression data by a small number of components also
enables use of statistical methods that assume independ-
ence. The significance testing itself is also multivariate, as
features are tested for significance in multiple dimensions
simultaneously. Genes that are not significant along any
of the individual components may still be important for
the full model.
The dimension reduction methods are applicable to a
wide range of problems. PCA is widely used for clustering
and for exploration of the main structure of a data set. In
this work, PCA revealed a large systematic variance in the
smoker data which was irrelevant for classification. A vis-
ual inspection of the scores clearly showed that a super-
vised decomposition was needed. PLSR has been much
used in the classification of expression data, and other
uses have been shown where the Y-information is non-
categorical. It is hard to control all levels of variability in
living organisms, and the responses to stimuli may differ
between test subjects. Similarly, biopsies used in cancer
classification are heterogeneous material and may vary
even among patients with the same diagnosis. The direct
use of clinical and pathological parameters in the analysis
may enable a more accurate modelling than if just the
classes or levels of a design are used.
While significance analysis by jack-knife is much used in
other fields [3], at least two new concepts are introduced
in this work. One is to use Bridge-PLSR to describe more
of the response variation in fewer components. This may
be needed when there is a large number of noisy or irrele-
vant variables in X, which is typical for expression data
analysis. For the rat-liver data, no discernible difference
was found between Bridge-PLSR and standard PLSR. For
the smoker data, PLSR was more predictive for future
objects, however, Bridge-PLSR was able to describe the
classes better and is preferred for significance analysis. It is
acknowledged also in [25] that the best genes for predic-
tion are not always the most interesting ones. The second
novel concept is the modified Hotelling's T2-test for use
with jack-knifed models. This test is believed to be supe-
rior to the standard alternative of performing a t-test for
each component individually.
There are several possible extensions to the presented
framework that may be included to handle more complex
problems. For instance, dimension reduction algorithms
exist that inherently handle missing data [4]. Often back-
ground information about the features are available, for
instance in the form of gene ontology or metabolic net-
works [26,27]. There are various ways to include a priori
information in the analysis, either in the form of a pre-
processing step or in a specialised algorithm [28]. The
dimension reduction methods are not even restricted to
two-way data. It is possible that a three-way organisation
of the rat-liver data into an array of time-by-dose for each
gene would result in a more stable decomposition. Several
possible dimension reduction methods exist also for
Bridge-PLSR X-loadings Figure 9
Bridge-PLSR X-loadings. Bridge-PLSR X-loadings for the rat-
liver data. Many significant features are found, and most of 
them are related to liver damage as described by the first 
component. Some significant genes are also found that span 
the time of exposure.
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arrays of higher order [29,30]. Finally, the presented
methodology is not restricted to expression data. Any bio-
informatics application producing many measured varia-
bles per available object can be expected to benefit from
these methods.
Conclusion
The dimension reduction methods are multivariate and
well suited to deal with the intricate network of depend-
encies between genes. They offer a versatility that allows
any continuous or discrete background information avail-
able to be incorporated in the analysis. The results are
intuitively understood based on simple scatter plots,
which also enable the discovery of unknown phenomena
in the data. The identification of differentially expressed
genes is an important part of expression data analysis. We
have presented a general scheme for significance testing
that can be applied to a wide range of dimension reduc-
tion methods. The validity of the procedure has been
established by comparison with other, well known algo-
rithms for significance analysis, by biological interpreta-
tion, and by analysis of spike-in data.
Methods
Data sets
The smoker data [15] contain expression levels for M =
7939 probe sets measured for N = 75 subjects on Affyme-
trix HG-U133A GeneChips (Affymetrix, Inc., USA). The
subjects are divided into 34 current smokers, 18 former
smokers and 23 individuals that have never been smok-
ing. The expression data are arranged in a matrix X of size
N rows by M columns, and the class information is con-
tained in a binary array Y. Each class is represented by a
column in Y, where a value of one assigns an object to that
class. X is logarithmically transformed prior to the analy-
sis. No other pre-processing or scaling is performed, that
is, we use the data directly as provided by Spira et al. [15].
The spike-in data [20] are obtained from a designed exper-
iment where 14 groups of three transcripts each were
spiked in at 14 different concentration levels in three rep-
licates. There is thus a total of N = 42 objects in the exper-
iment, corresponding to specific concentration mixtures.
Expression levels were measured on a modified Affymetrix
HG-U133A array, and concentrations ranging from zero
to 512 pM were arranged in a Latin square setup. The 42
spike-in genes were measured in a constant human back-
ground, 22300 probe sets in total. The data are pre-proc-
essed using the gcrma-package [31], which is part of the
Bioconductor project [32]. As groups of three transcripts
are spiked in at the same amounts, the response matrix Y
contains 14 concentration profiles, one for each group.
Several authors have remarked that some of the back-
ground genes show consistent differential expression
across the experiments [21-23]. Some of those genes con-
tain sequences which match the spike-ins exactly. We
therefore adopt the extended spike-in gene-list given by
McGee and Chen [22], yielding a total of 64 entries. The
list is identical to the one suggested by Lo and Gottardo
[23], except the probe set "205397_x_at" is removed. This
probe set has identical sequence to the originally included
"205398_at" for 5 of 11 probes. Due to memory limita-
tions, there is a need to filter away some genes before the
analysis. We therefore include only those normalised
probe sets with a standard deviation above 0.4, which
results in a total of M = 14.490 variables in X. Potential
alternatives to filtering would have been to apply a leave-
two-out cross-validation, or to use fewer Y-variables or
components in the analysis.
In the liver toxicity study [24], male rats of the inbred
strain Fisher 344 were administered non-toxic (50 or 150
mg/kg), moderately toxic (1500 mg/kg) or severely toxic
(2000 mg/kg) doses of paracetamol in a controlled exper-
iment. Necropsies were performed at 6, 18, 24 and 48
hours after exposure. RNA analysis was performed on an
Agilent platform (Agilent Technologies, USA), and four
biological replicates were obtained for each of the 16
design-points. All spots flagged as bad or not found by the
image analysis program are removed. In addition, spots
are removed if they have total intensity less than 200, fore-
ground to background intensity less than 1.5, spot diam-
eter less then 25 pixels, or more than 50% of pixels
saturated. As the background estimates available in the
Agilent image analysis report are local backgrounds meas-
ured in pixels near the spots, it is doubtful if this is a useful
estimate of the background in the spot [33]. Therefore, no
background correction is done. The filtered data are trans-
formed to log2-ratios and normalised using global loess to
improve colour balance and remove global intensity
effects [34]. Ratios for spots that have been removed in the
filtering are imputed using k-nearest neighbours with k =
10 [35]. Two histological and ten clinical variables con-
taining markers for liver injury are available for each
object. The expression data are arranged in a matrix X of
N = 64 objects and M = 7445 expression levels. For analy-
sis by SAM, the two non-toxic levels are pooled in a group
of low dose, and the two toxic levels are pooled in a group
of high dose. The data are further divided into groups for
each of the four time-points, giving a total of 8 groups to
be tested for differential expression. In the bilinear analy-
sis, a matrix Y of 14 columns is constructed instead that
contains the design information of dose and time as well
as the phenotypic responses available. A description of all
the variables in Y are given in figure 8. The Y-variables
SDH, BILE, AST and ALT are log-transformed in order to
get responses which are more closely bell-shaped.BMC Bioinformatics 2007, 8:346 http://www.biomedcentral.com/1471-2105/8/346
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Bridge-PLS regression
PLSR finds linear combinations (scores) of the original
features spanning directions of high covariance between X
and Y. In the most common PLSR implementation, the
data are deflated each time a component is found, by sub-
traction of that component from the remaining X-data.
This ensures that each score vector is orthogonal to all pre-
vious components. It also enables better model fit, as sev-
eral components are allowed in the modelling of each
individual response. Cross-validation is usually applied to
find the number of components which yields the best pre-
dictions [3]. However, the best prediction model does not
necessarily contain the most informative components. If a
single response is modelled (i.e. if Y has only one col-
umn), qualitatively useful information is expected from
the vector of covariances between the variables in X and
the response [36,37]. The covariances are given by the so-
called loading weights corresponding to the first compo-
nent, and this vector is therefore well suited for signifi-
cance analysis. Subsequent loading weights are less
interpretable, as they, due to the deflation step, may be
influenced by information in X unrelated to Y. In order to
obtain informative weights for multiple responses, it is
possible to make one PLSR-model for each individual
response. Such an approach was taken e.g. in [9], where
cell cycle regulated genes were found using the first load-
ing weight from two single-response PLSR-models.
Bridge-PLSR has no deflation step, and the loading
weights are used directly in the model rather than calcu-
lating new loadings [14]. If the ridge-parameter γ is set to
zero, Bridge-PLSR is simply a singular value decomposi-
tion of the covariance matrix X'Y, with a subsequent pre-
diction relation between X and Y. At the other extreme,
when γ = 1, Bridge-PLSR becomes an ordinary principal
component regression [3]. Any intermediate value of γ
corresponds to some weighted average between those two
methods. For significance analysis, and for interpretation
of components in relation to Y, the optimal value of γ is
zero. The loadings will then collectively explain the same
Y-information as the set of loading weights from all one-
component, individual response PLSR-models. For multi-
ple correlated responses, Kvalheim [38] recommends
orthogonalisation of Y  before calculating such single-
response models. This ensures that the models will be
close to orthogonal to each other as long as the predictive
relation between X and Y is good. These steps are all cir-
cumvented with Bridge-PLSR, as the Bridge-PLSR loadings
are orthogonal by default. In addition, a single, predictive
Bridge-PLSR model is more useful and appealing to work
with than multiple single-response PLSR-models.
When γ = 0, the maximum number of components equals
the sum of independent responses in Y. If all these com-
ponents are used, the residuals will be orthogonal to Y,
and the loadings (= loading weights) will together
account for all the Y-related information in X. Because
only one component is available for each orthogonal
response when γ = 0, the predictive ability of Bridge-PLSR
is often less than that of an ordinary PLSR. However, a
tuning of the γ-parameter may increase the predictive abil-
ity of the model. This is expected for instance in cases
where Y is large or noisy compared to X. It is also seen
from the response surfaces provided in supplementary
information that a larger γ-value may stabilise the decom-
position such that early local minima are avoided. How-
ever, the response surfaces provided are not validated by
an external validation and should not be used for optimi-
sation. Any such tuning of parameters should be accom-
panied for instance by cross model validation to avoid
optimistically biased results [19,39].
For the analysis in this work, γ is set to the small default
value of 0.01. It is seen from the response surfaces in sup-
plementary information that this yields the same predic-
tive ability (down to two decimals) as if γ were zero. Also,
the components obtained using the two values of γ are
qualitatively equal, such that the influence on the signifi-
cance analysis is negligible. The γ-parameter is given this
value only to enable interpretation of more than two com-
ponents for the smoker data, although these components
are not used in the jack-knife. Bridge-PLSR is algorithmi-
cally simple, and the models are validated by cross-valida-
tion or test sets in a straight forward manner.
Pseudo-code Bridge-PLSR
1. Start with column-centred X and Y
2. Find by SVD Y = UySy
3. Construct a representation of Y that has the rank of X:
G = (1 - γ) UySy  + γI
4. Find by SVD XTG = USVT
5. Loadings PA given by the A largest components in U
6. Scores TA = XPA
7. Y-loadings QA = YTTA( TA)-1
8. Regression coefficients B = PA
9. Predictive relation  , where the offset
Vy
T
Uy
T
TA
T
QA
T
ˆ Y1 b X B =+ 0
T
by B x 0 =− TBMC Bioinformatics 2007, 8:346 http://www.biomedcentral.com/1471-2105/8/346
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Optional extensions
Even though all the Y-related information is accounted for
in Bridge-PLSR, the model may also include variance
which is orthogonal to Y. Such orthogonal variance is the
reason the smoker-classes are not better separated in fig-
ure 4. In a perfectly fitted model, all the samples of either
class would appear as a single spot in the score plot, such
that the three classes formed a triangle. In general, perfect
fit is not a goal, as such a model would describe also meas-
urement noise and other artifacts. However, in cases with
much irrelevant X-variation, removal of some unwanted
structures might improve the analysis. At least three
approaches can be taken to this end. Variable selection
attempts to remove the least relevant variables from X,
improving the subsequent data-analysis [19]. Target rota-
tion of PLSR loading weights toward orthogonalised
responses will improve the fit provided the number of ini-
tial components is sufficiently high [37,38]. Target rota-
tion of two Bridge-PLSR components toward two
independent responses will give no improvement, as the
Bridge-PLSR loadings already span the directions of inter-
est (when γ = 0). A third approach is to use some sort of
orthogonal signal correction, a family of methods which
separate components from X which are orthogonal to Y
[40,41]. The method of 02-PLS [40] is especially interest-
ing, as this model formulation is very similar to Bridge-
PLSR. In a test using the smoker data, target rotation based
on five PLSR components gave similar results as an O2-
PLS model where three orthogonal components had been
removed (not shown).
Removal of some unwanted X-information may increase
the predictive ability and find even more relevant genes.
However, all the above procedures for improving the
modelling are based on the data themselves, which means
that degrees of freedom are in effect removed from X. It
follows that the risk of overfit increases the more the data
are manipulated. As an example, a perfect fit will always
result when a target rotation is based on all data, or when
all orthogonal components are removed from the model.
Much caution and good knowledge of the data are there-
fore advised when any of the above procedures are imple-
mented. As these methods are useful only for data with
much irrelevant X-variation, we have chosen not to
include them further in this work. As was demonstrated
with the smoker-data, Bridge-PLSR will find the important
directions in the data no matter how much irrelevant X-
structure is present.
Significance analysis
A cross-validation using an appropriate dimension reduc-
tion method is performed, and loadings from each sub-
model with left-out objects is obtained. The perturbed
loadings are used to estimate the stability of each feature.
The optimal number of components A for prediction, and
the overall predictability of the model may be estimated
as described in [3]. Only components that lead to a signif-
icant decrease in the cross-validated prediction error
should then be included. In this work, we concentrate
more on significance analysis than on optimisation of
prediction models, and interpretation of score plots is
therefore at least as important when A is found.
Many of the dimension reduction methods yield orthon-
ormal loadings, in which cases the relative importance of
the components are reflected by the length of the scores.
For the significance analysis, it is important that the load-
ings themselves are weighted by the variance of their com-
ponents. All perturbed loadings from the cross-validation
also have to be aligned properly. A bilinear model can be
written on the form  , where C is
any invertible matrix of rank A. This means that the com-
ponents have full rotational freedom, and it is often
observed that a component is flipped 180° in one sub-
model relative to another. Components of similar eigen-
values may also be sorted differently in different sub-
models. A Procrustes rotation of the perturbed models
toward the calibration model will correct for these incon-
sistencies [3]. We perform un-centred and un-scaled rota-
tions of all loadings prior to significance testing.
Each variable (gene) is tested under the null hypothesis
that its corresponding loading-parameter is zero in the A-
dimensional space spanned by the components. It follows
that the choice of dimension reduction is very important
for the outcome of the test. Figures 1 and 2 show that
components spanning only irrelevant X-variation will
yield irrelevant genes. On the other hand, when the com-
ponents describe some Y-information of interest, we
directly find the features important for the different
responses (e.g. figures 4 and 5). Hotelling's T2-test is able
to assess the significance of parameters in several dimen-
sions simultaneously. We have modified the test to make
it more suited for jack-knife of bilinear model parameters.
Some of these modifications are described in [3,12] for
the regular one-sample t-test. The variation of the per-
turbed sub-models around an estimated true model
describes the stability for each gene. Traditionally, the
mean of the sub-models represents the centre points, but
the median or even the full calibration model may also be
used. Because the perturbed models are not independent
of the full model, the deviations are summed instead of
averaged. The latter point makes a difference if the actual
value of the T2-score is interpreted, not if the T2-score is
used simply as a ranking of the genes. Finally, shrinkage
of the gene-specific variances toward a total variance
across genes is included [25]. This is to avoid poorly esti-
mated variances due to the small number of objects in
ˆ XT P T C C P ==−
AA
T
AA
T 1BMC Bioinformatics 2007, 8:346 http://www.biomedcentral.com/1471-2105/8/346
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microarray experiments. A shrinkage factor of zero means
that every gene is evaluated individually, while a factor of
one treats all genes as having equal variances. The actual
value of the parameter is a choice that must be made on
the basis of the number of replicates and the overall data
quality. Poor quality data and few replicates may justify
increased shrinkage.
The T2-score for gene i ∈ {1,..., M} is given as
The vector pi is of length A and represents the true load-
ings, β ∈ [0, 1] is the shrinkage factor,   is a matrix of
size K-by-A holding the loadings from the K sub-models
and 1 is a vector of ones. Stot is the mean or median of the
scaled, gene-specific variance-covariance matrices 
across all genes. The scaling   is taken from [3]
and is close to one in most cases. In this work, pi is the
mean value over sub-models, the coefficient β = 0.1 and
the median of covariances is used to find Stot.
FDR estimation
We adapt the definition of the positive false discovery rate
[42], which states that
FP and TP are the numbers of false and true positives,
respectively. A q-value ∈ [0, 1] assigned to each gene gives
the minimum FDR that results in a rejected hypothesis for
that feature. An FDR significance level cutoff is applied to
the q-values to decide which features to call significant.
The conditional statement that the sum of positive out-
comes must be larger than zero can often be disregarded
in practice. It is then possible to estimate the q-values by
resampling, using the relation
Every feature i is associated with a score  . The denomi-
nator holds the total number of genes at least as signifi-
cant as this based on the calibration model. The number
of false positives at the same significance level is not
known, and must be estimated. The estimated count for
gene i is found by reshuffling and denoted  i. The rows
of Y are shuffled R times to give several matrices  , r ∈
{1,..., R}, with random object-information only. A jack-
knife based on one of the randomised matrices is expected
to give no true positives, especially if the number of signif-
icant features is small compared to the total number of
features tested. Here,   is found as the median number
of significant outcomes over R = 1000 shuffled responses,
and all features with   smaller than a pre-set significance
level α are called significant. Estimation of   when no Y
is available is difficult, because it is not possible to shuffle
X for each feature separately without simultaneously dis-
rupting all other systematic structure in the data. For the
smoker-data, we have therefore used the same number of
significant features for PCA as we found for Bridge-PLSR.
The FDR significance level is set to α  = 0.05 for the
smoker-data and to α = 0.01 for the spike-in data. Because
the relevant signal in the paracetamol data set is very
strong, a significance level of α = 0.001 is enough to get a
large number of significant features for these data.
SAM and Limma analysis
SAM and Limma are used to identify differentially
expressed genes in the smoker data set. Both methods are
part of the Bioconductor software (Version 1.9) [32], and
we use the packages limma and siggenes for Limma and
SAM, respectively. Limma is performed with the functions
lmFit and eBayes with default settings. We control Ben-
jamini and Hochberg's FDR at a level of α using the func-
tion decideTests. SAM is run with the function sam.dstat
with 1000 permutations, the parameter delta = 0.8 and the
remaining parameters at default setting.
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